MetLife (MET)
(Delayed Data from NYSE)
$78.56 USD
+0.13 (0.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $78.57 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.56 USD
+0.13 (0.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $78.57 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
3 Top Dividend Stocks to Maximize Your Retirement Income - January 31, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - January 24, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Prudential's (PRU) Unit Expands Travel Assistance Offerings
by Zacks Equity Research
Prudential's (PRU) arm chooses IMG to upgrade its travel assistance suite and a new insurance product.
Why is Hold Strategy Appropriate for CNO Financial (CNO) Now?
by Zacks Equity Research
Riding high on its growing top line, reducing costs and an impressive capital position, CNO Financial (CNO) is well placed to benefit its investors.
Zacks Value Trader Highlights: Brighthouse Financial, Credit Suisse, MetLife, Penn National Gaming and Signet
by Zacks Equity Research
Zacks Value Trader Highlights: Brighthouse Financial, Credit Suisse, MetLife, Penn National Gaming and Signet
Where to Find the Best Classic Value Stocks Right Now
by Tracey Ryniec
Growth stocks continue to be sizzling hot in 2020 but value investors shouldn't despair. There are still stocks with attractive fundamentals and great Zacks Ranks.
3 Top Dividend Stocks to Maximize Your Retirement Income - January 09, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Avoid AIG, Add These 3 Insurance Stocks to Your Portfolio
by Srijita Guha
While AIG's headwinds weigh on its margins, other industry players look attractive with high prospects.
Add These 3 High Yield Dividend Stocks to Portfolio for 2020
by Swayta Shah
High yield dividend stocks are an attractive investment option for income investors.
MetLife Hits New 52-Week High: What's Driving the Rally?
by Sapna Bagaria
MetLife (MET) benefits from recent deals and strong operating performance.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Top Dividend Stocks to Maximize Your Retirement Income - January 03, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Cigna Considers Divesting Its Non-Health Insurance Business
by Zacks Equity Research
Speculations ran rife that Cigna (CI) is on the lookout of a bidder for its non-health insurance arm to streamline in-house operations.
MetLife to Foray Into Pet Insurance Via PetFirst Acquisition
by Zacks Equity Research
MetLife (MET) to acquire PetFirst to enter the rapidly growing pet insurance market.
MetLife (MET) to Provide Estate Planning Via Willing Buyout
by Zacks Equity Research
MetLife (MET) agrees to acquire Willing and provide online estate planning services to its group customers.
Q3 Earnings Push Insurance ETFs Higher
by Sweta Killa
The Q3 earnings of insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past month.
MetLife (MET) Q3 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
MetLife (MET) Q3 earnings suffer from high expenses, which offset revenue growth.
MetLife (MET) Lags Q3 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -9.93% and 3.36%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for MetLife (MET)
by Zacks Equity Research
MetLife (MET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can MetLife (MET) Maintain Its Earnings Beat Streak in Q3?
by Sapna Bagaria
MetLife's (MET) Q3 earnings are likely to have gained from higher premiums and share buyback partly offset by lower investment income.
MetLife (MET) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
MetLife (MET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why MetLife (MET) Could Beat Earnings Estimates Again
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bleak Near-Term Outlook for Multiline Insurance Industry
by Tanuka De
The Multiline Insurance Industry should benefit from better pricing and a solid capital level. However, a declining rate environment is a concern.